Evidence map›Paper›PMID 31539646›Full record

ArticlePapillomavirus research (Amsterdam, Netherlands)2019

Diversity of human papillomavirus typing among women population living in rural and remote areas of Brazilian territory.

Adriana Tarlá Lorenzi, José Humberto Fregnani, Luisa Lina Villa, Laura Sichero, Emily Montosa Nunes, Adhemar Longatto-Filho

Abstract read
In one paragraph

Article in Papillomavirus research (Amsterdam, Netherlands), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Genetic and Epigenetic Variations of HPV52 in Cervical Precancer.International journal of molecular sciences · 2021
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adriana Tarlá LorenziTeaching and Research Institute, Molecular Oncology Research Center, Barretos Cancer Hospital, Pio XII Foundation, Brazil; Teacher at Faculty of Medicine, Alfredo Nasser Faculty (UNIFAN), Goiás, Brazil.
José Humberto FregnaniTeaching and Research Institute, Molecular Oncology Research Center, Barretos Cancer Hospital, Pio XII Foundation, Brazil; Superintendence of Education of A.C.Camargo Cancer Center, Brazil.
Luisa Lina VillaMolecular Biology Laboratory, Center for Translational Research in Oncology, Instituto do Cancer do Estado de Sao Paulo - ICESP, São Paulo, Brazil; Department of Radiology and Oncology, School of Medicine, Universidade de São Paulo, Brazil.
Laura SicheroMolecular Biology Laboratory, Center for Translational Research in Oncology, Instituto do Cancer do Estado de Sao Paulo - ICESP, São Paulo, Brazil.
Emily Montosa NunesMolecular Biology Laboratory, Center for Translational Research in Oncology, Instituto do Cancer do Estado de Sao Paulo - ICESP, São Paulo, Brazil.
Adhemar Longatto-FilhoTeaching and Research Institute, Molecular Oncology Research Center, Barretos Cancer Hospital, Pio XII Foundation, Brazil; Medical Laboratory of Medical Investigation (LIM) 14. Department of Pathology, Faculty of Medicine, Universidade de São Paulo, Brazil; Research Institute of Life and Health Sciences (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS / 3B's - Associated Laboratory to the Government of Portugal, Braga, Guimarães, Portugal. Electronic address: http://www.icvs.uminho.pt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesGenotyping HPV from samples tested positive to careHPV™ assay in rural and remote areas of Brazilian territory.

methodsA total of 5079 women were enrolled in an opportunistic screening from the Barretos Cancer Hospital, through mobile units or ambulatory unit. All careHPV™ hr-HPV positive samples were tested by a Luminex-based protocol in order to evaluate the HPV infecting types.

resultsPositive hr-HPV results were obtained in 10.6% (536/5068) of women. Among these cases, HPV-56 and HPV-51 were the most common types detected in 32.3% and 31.4%, respectively. HPV-53 (20.5%), HPV-18 (18.5%), HPV-58 (17.6%), HPV-52 (16.0%) and HPV-16.6%) were the other most frequent types detected. These frequencies represent prevalences of 2.35%, 2.12%, 2.02%, 1.84% and 1.80% respectively, within the population studied. Regarding low-risk HPVs, HPV-6 was detected in 12.9% of the samples. The less frequent types (<3%) were: HPV-70, HPV-11 and HPV-26.

conclusionsThe most frequent types detected were: HPV-56, HPV-51, HPV-53, HPV-18, HPV-58, HPV-52 and HPV-16 according to decreasing rates.

Indexed as

Rural PopulationAdultBrazilDNA, ViralEarly Detection of CancerFemaleGenotypeHuman Papillomavirus DNA TestsHumansMass ScreeningMiddle AgedPapillomaviridaePapillomavirus InfectionsPublic Health SurveillanceRetrospective StudiesUterine Cervical NeoplasmsDNA, ViralCervical cancerCervix neoplasms preventionGenotypeHuman papillomavirus DNA testsScreeningSelf-examination

Identifiers

PMID31539646
PMCPMC6804508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.